Strikingly, these mutations are also detected in ALL patient samples and at the CRLF2 ABC in healthy Hispanic donors, indicating that off-target activity of AID at CRLF2 occurs during B cell maturation and can be a risk factor of Ph-like ALL development. The gene discussed is CRLF2; the disease is acute lymphoblastic leukemia.